KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Current Liabilities (2016 - 2026)

Quest Diagnostics' Total Current Liabilities history spans 18 years, with the latest figure at $2.2 billion for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 51.08% to $2.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 billion, a 51.08% increase, with the full-year FY2025 number at $2.3 billion, up 5.03% from a year prior.
  • Total Current Liabilities hit $2.2 billion in Q1 2026 for Quest Diagnostics, down from $2.3 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for DGX hit a ceiling of $2.3 billion in Q1 2024 and a floor of $1.4 billion in Q1 2023.
  • Historically, Total Current Liabilities has averaged $1.9 billion across 5 years, with a median of $1.9 billion in 2023.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 69.59% in 2024 and later tumbled 37.29% in 2025.
  • Tracing DGX's Total Current Liabilities over 5 years: stood at $1.6 billion in 2022, then increased by 17.02% to $1.8 billion in 2023, then grew by 19.5% to $2.2 billion in 2024, then rose by 5.03% to $2.3 billion in 2025, then dropped by 4.43% to $2.2 billion in 2026.
  • Business Quant data shows Total Current Liabilities for DGX at $2.2 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.1 billion in Q3 2025.